Clough Capital Partners’s Medtronic MDT Stock Holding History

Clough Capital Partners’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-6,000	Closed	-$571K	–	121
2025 Q3	$571K	Hold	6,000	–	–	0.05%	108
2025 Q2	$523K	Hold	6,000	–	–	0.05%	108
2025 Q1	$539K	Hold	6,000	–	–	0.07%	93
2024 Q4	$479K	Hold	6,000	–	–	0.05%	107
2024 Q3	$540K	Sell	6,000 -6,900	-53%	-$580K	0.06%	115
2024 Q2	$1.02M	Sell	12,900 -2,700	-17%	-$221K	0.11%	90
2024 Q1	$1.36M	Hold	15,600	–	–	0.15%	77
2023 Q4	$1.29M	Sell	15,600 -16,300	-51%	-$1.24M	0.14%	95
2023 Q3	$2.5M	Hold	31,900	–	–	0.27%	81
2023 Q2	$2.81M	Hold	31,900	–	–	0.28%	97
2023 Q1	$2.57M	Hold	31,900	–	–	0.28%	94
2022 Q4	$2.48M	Buy	+31,900	New	+$2.59M	0.25%	85
2016 Q4	–	Sell	-6,700	Closed	-$579K	–	185
2016 Q3	$579K	Sell	6,700 -32,100	-83%	-$2.8M	0.03%	148
2016 Q2	$3.37M	Sell	38,800 -5,500	-12%	-$445K	0.18%	119
2016 Q1	$3.32M	Buy	+44,300	New	+$3.34M	0.16%	122

Other funds holding MDT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Clough Capital Partners's MDT Position: Q4 2025 in Review

Clough Capital Partners sold out of Medtronic (MDT) in Q4 2025, closing a stake of 6,000 shares — an estimated $571K sold.

Clough Capital Partners first reported a position in MDT in Q1 2016 and held it in 15 quarters. The position peaked at $3.37M in Q2 2016. 2,312 funds tracked by Wall St. Rank hold MDT as of Q4 2025.

Clough Capital Partners reported no remaining Medtronic position as of Q4 2025 after selling out during the quarter.
Clough Capital Partners sold 6,000 Medtronic shares in Q4 2025, an estimated $571K.
Clough Capital Partners first reported a position in Medtronic in Q1 2016 and held it in 15 quarters.
Clough Capital Partners's Medtronic position peaked at $3.37M in Q2 2016.
2,312 funds tracked by Wall St. Rank held Medtronic as of Q4 2025.

Based on Clough Capital Partners's 13F filing for Q4 2025, filed 17 Feb 2026.